Bedside testing for precise warfarin dosing in heart patients
Part of Blood & lymphatic clinical trials.
This study tests a new way to monitor and adjust warfarin (a blood thinner) using a simple bedside test, aiming to make dosing more precise. Participation may help you get faster and more personalized dose adjustments while you are in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be an inpatient in a cardiology or heart surgery unit and starting warfarin for the first time.
- You need to be willing to take warfarin for at least 3 months continuously.
- You cannot have known genetic test results for CYP2C9 or VKORC1 genes.
- You cannot have upcoming surgery, bleeding risk, severe heart failure, severe anemia, kidney/liver problems, cancer, or uncontrolled high blood pressure.
- If you are pregnant or breastfeeding, you cannot participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new device that may quickly measure how well your blood clots while you are on a blood thinner. They will take a small blood sample to see if the device works well for patients like you.
This study tests a new blood test called ClotChek™ to see how well it works for people taking direct oral anticoagulants (DOACs), a type of blood thinner. You would give a blood sample, and the test may help doctors better monitor your medication.
This study looks at why some people process warfarin (a blood-thinning medicine) differently. It aims to learn what personal or medication factors may affect how well warfarin works, so future dosing can be safer and more accurate.
This trial tests a new device that might make monitoring warfarin levels easier during blood donation. It could help you manage your blood thinner treatment more conveniently.
This study tests a better way to manage warfarin (a blood thinner) for people with atrial fibrillation (an irregular heartbeat). The goal is to improve treatment and help prevent stroke.
This trial tests a new lab device that measures how well your body forms primary blood clots while blood is kept in flowing conditions. It may help doctors better assess bleeding or clotting tendencies and guide future care.
Hear when a new Anticoagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.